tiprankstipranks
Advertisement
Advertisement

HK:2171 Stock Latest News

CARsgen Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
Company AnnouncementsCARsgen Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
4d ago
CARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme
PremiumCompany Announcements
CARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme
1M ago
CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors
PremiumCompany Announcements
CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors
1M ago
CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall
PremiumCompany Announcements
CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall
1M ago
CARsgen Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
CARsgen Schedules Board Meeting to Approve 2025 Annual Results
2M ago
CARsgen to Invest RMB370 Million in New CAR T Manufacturing Base in Shanghai
PremiumCompany AnnouncementsCARsgen to Invest RMB370 Million in New CAR T Manufacturing Base in Shanghai
2M ago
CARsgen Flags Sharp Narrowing of 2025 Losses on CAR-T Commercial Gains
Premium
Company Announcements
CARsgen Flags Sharp Narrowing of 2025 Losses on CAR-T Commercial Gains
3M ago
CARsgen Extends Share Buyback Plan as Major Shareholder Raises Stake
Premium
Company Announcements
CARsgen Extends Share Buyback Plan as Major Shareholder Raises Stake
4M ago
CARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress
PremiumCompany Announcements
CARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress
4M ago
CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder
PremiumCompany Announcements
CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder
5M ago
2171
CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy
PremiumCompany Announcements
CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy
6M ago
2171
CARsgen Presents Promising Results for Satri-cel at ESMO Congress 2025
PremiumCompany Announcements
CARsgen Presents Promising Results for Satri-cel at ESMO Congress 2025
6M ago
2171
CARsgen to Present CT0596 Research at ASH 2025
PremiumCompany AnnouncementsCARsgen to Present CT0596 Research at ASH 2025
6M ago
2171
CARsgen Therapeutics Announces Board Composition and Roles
Premium
Company Announcements
CARsgen Therapeutics Announces Board Composition and Roles
7M ago
2171
CARsgen Therapeutics Announces Passing of Key Non-Executive Director
Premium
Company Announcements
CARsgen Therapeutics Announces Passing of Key Non-Executive Director
7M ago
2171
CARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests
PremiumCompany Announcements
CARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests
7M ago
2171
CARsgen Presents Updated Results for Zevor-cel at IMS Meeting
PremiumCompany Announcements
CARsgen Presents Updated Results for Zevor-cel at IMS Meeting
7M ago
2171
CARsgen Enhances Governance with New Committee
PremiumCompany Announcements
CARsgen Enhances Governance with New Committee
7M ago
2171
CARsgen Therapeutics Reports Improved Financial Results for H1 2025
PremiumCompany Announcements
CARsgen Therapeutics Reports Improved Financial Results for H1 2025
8M ago
2171
CARsgen Therapeutics to Review Interim Results in Upcoming Board Meeting
PremiumCompany AnnouncementsCARsgen Therapeutics to Review Interim Results in Upcoming Board Meeting
9M ago
2171
CARsgen Therapeutics Projects Reduced Losses Amid Increased Revenues
Premium
Company Announcements
CARsgen Therapeutics Projects Reduced Losses Amid Increased Revenues
9M ago
2171
CARsgen’s Satri-cel Trial Results Accepted for ESMO 2025
Premium
Company Announcements
CARsgen’s Satri-cel Trial Results Accepted for ESMO 2025
9M ago
2171

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >